<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PBMA | Foss Cain | Activity</title>
	<link>https://pbmaoffroad.org/members/peruvein54/activity/</link>
	<atom:link href="https://pbmaoffroad.org/members/peruvein54/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Foss Cain.</description>
	<lastBuildDate>Wed, 06 May 2026 01:51:20 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7cf6a7466e86a1a632ea53c888442749</guid>
				<title>Foss Cain posted an update: Understanding Ozempic UK Price: An In-Depth [&#133;]</title>
				<link>https://pbmaoffroad.org/activity/p/144718/</link>
				<pubDate>Wed, 04 Mar 2026 07:45:43 +0000</pubDate>

									<content:encoded><![CDATA[<p>Understanding Ozempic UK Price: An In-Depth Overview</p>
<p>Ozempic (semaglutide) has actually acquired significant attention as an innovative drug in the management of type 2 diabetes and, more recently, for weight-loss. In the UK, numerous people looking for treatment or assessment might have concerns surrounding the rates of Ozempic. This article&hellip;<span class="activity-read-more" id="activity-read-more-144718"><a href="https://pbmaoffroad.org/activity/p/144718/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9253c1d46e23231ab22e258c2f1cc478</guid>
				<title>Foss Cain became a registered member</title>
				<link>https://pbmaoffroad.org/activity/p/144574/</link>
				<pubDate>Wed, 04 Mar 2026 07:25:48 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>